Abstract
Leiomyomas are the most common mesenchymal neoplasms. Smooth muscle cells with variable amounts of fibrous stroma make up these benign tumors. The tumor occurs most frequently in uterus in 20–30% of women of reproductive age. Uterine leiomyosarcoma (uLMS/LMS) is a rare cancer originating from smooth muscle lining the walls of the uterus. We report a case of postmenopausal women of 65 years presented with retention urine, diagnosed as LMS of uterus on histopathology.
Publisher
Innovare Academic Sciences Pvt Ltd
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology
Reference29 articles.
1. Brooks SE, Zhan M, Cote T, Baquet CR. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol Oncol 2004;93:204-8. doi: 10.1016/j.ygyno.2003.12.029, PMID 15047237
2. Kaur K, Kaur P, Kaur A, Singla A. Uterine leiomyosarcoma: A case report. J Mid Life Health 2014;5:202-4. doi: 10.4103/0976- 7800.145175, PMID 25540573
3. Parker WH, Fu YS, Berek JS. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 1994;83:414-8. PMID 8127535
4. Ricci S, Stone RL, Fader AN. Uterine leiomyosarcoma: Epidemiology, contemporary treatment strategies and the impact of uterine morcellation. Gynecol Oncol 2017;145:208-16. doi: 10.1016/j. ygyno.2017.02.019, PMID 28209496
5. Giunchi S, Perrone AM, Tesei M, Bovicelli A, De Crescenzo E, Dondi G, et al. Sonographic imaging in uterine sarcoma: A narrative review of literature. Gynecol Pelvic Med 2022;5:14. doi: 10.21037/gpm-21-20